Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Advanced Medical Isotope Corporation Banking On Expanded Distributino and Radiogel Technology

(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.



In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future



Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.



Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.



AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.



Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.



That places AMIC right in the middle of a potential growth boom.



While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.



In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.



Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.



Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.



It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.



Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.



Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.



Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.



That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.



Still a developing story worth monitoring.



Disclosure: No position.



Follow ADMD developments and other small cap stocks at VFCsStockHouse.com



Contact VFC's Stock House: vfc@vfcsstockhouse.com



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com

VFC's Stock House

VFC

240-786-2111

vfc@vfcsstockhouse.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


China regulator to launch drug pricing probe in June
26 May 2016 at 7:44pm

China will carry out wide-ranging pricing inspections on drug firms, hospitals and procurement bodies from June 1, the country's top watchdog said on Friday, extending a tough cost-cutting campaign to reduce the price of healthcare. The National Development and Reform Commission (NDRC) said in a statement it would carry out the probes from June 1 until the end of October, checking the "pricing behavior" of drug firms and related institutions. Local media reported earlier this month that China was planning to launch "large-scale and systematic" anti-trust investigation into foreign and local drug firms.


The Color Purple: Biological, Sorority, and Lupy Sisters
26 May 2016 at 6:27pm
"I think it pisses God off if you walk by the color purple in a field somewhere and don't notice it." -Shug Avery in the Color PurpleIt's likely that Alice Walker wasn't thinking about Takisha Mundy and Amy Meachum when she sat down to write her award winning novel, "The Color Purple." Takisha was just beginning elementary school while Amy...

Theranos sued over blood tests, in proposed class action
26 May 2016 at 5:47pm
(Reuters) - Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers. The proposed class action was brought in the U.S. District Court for the Northern District of California by the law firm Hagens Berman Sobol Shapiro LLP. It estimated that thousands of consumers could be eligible to join the lawsuit, citing Theranos? claims that it had performed more than 6 million tests.


U.S. sees first case of bacteria resistant to all antibiotics
26 May 2016 at 5:35pm

U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave concern that the superbug could pose serious danger for routine infections if it spreads. "We risk being in a post-antibiotic world," said Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, referring to the urinary tract infection of a 49-year-old Pennsylvania woman who had not travelled within the prior five months. Frieden, speaking at a National Press Club luncheon in Washington, D.C., said the infection was not controlled even by colistin, an antibiotic that is reserved for use against "nightmare bacteria." The infection was reported Thursday in a study appearing in Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology.


At G7, Britain presses for global reward system for new antibiotics
26 May 2016 at 4:06pm
By Kylie MacLellan ISE-SHIMA, Japan (Reuters) - Britain is pushing for a global plan to reward drugs companies for developing new antibiotics, while also pledging to cut antibiotic use in England. Former Goldman Sachs chief economist Jim O'Neill, who led the review, said a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market. British Prime Minister David Cameron will say at the G7 meeting in Japan on Friday that Britain will work with global finance and health experts to develop such as system to bring the new antibiotics to market and make them available to all who need them.


Report: 1st US case of germ resistant to last resort drug
26 May 2016 at 4:03pm

NEW YORK (AP) ? For the first time, a U.S. patient has been infected with bacteria resistant to an antibiotic used as a last resort treatment, scientists said Thursday.



Trump, Sanders explore an unconventional presidential debate
26 May 2016 at 3:15pm

By Emily Stephenson BISMARCK, N.D. (Reuters) - Republican Donald Trump and Democrat Bernie Sanders on Thursday explored staging an unconventional U.S. presidential debate that would sideline Democratic front-runner Hillary Clinton but create a high-ratings television spectacle. The two men - a billionaire and a democratic socialist - expressed interest in a one-on-one encounter in California even though Republican and Democratic presidential candidates traditionally do not debate each other until the parties have selected their nominees. "I'd love to debate Bernie," Trump told reporters in North Dakota, after he secured enough delegates to clinch the Republican presidential nomination.



Our Bicycles, Ourselves
26 May 2016 at 2:46pm

We love to ride. The camaraderie of riding in a peloton, or the solo inspiration of riding and day dreaming, keeps us on our bikes for hours. We adjust our diets to get leaner. We drink fluids loaded with carbohydrates. Even the clothes we wear are designed to highlight our slim bodies, while diminishing their wind resistance. Over time, our...



'Nightmare' infection found in US for first time
26 May 2016 at 2:40pm

A superbug resistant to all known medications has been found in the United States for the first time, raising new concern about the dwindling effectiveness of antibiotics, the top US public health official said on Thursday. The case involved a 49-year-old woman in Pennsylvania whose urinary tract infection tested positive for a strain of E. coli that is resistant to the antibiotic of last resort for such infections, known as colistin. "It was an old antibiotic, but it was the only one left for what I call nightmare bacteria," a family of germs known as carbapenem-resistant Enterobacteriaceae (CRE), said Thomas Frieden, chief of the US Centers for Disease Control and Prevention.



Look Within: Energetic Solutions to Increase Success
26 May 2016 at 2:39pm

Look Within: Energetic Solutions to Increase SuccessWe all pursue success - but why are some of us better at achieving our goals than others?This was a question I asked myself as a competitive athlete, then as a coach, and finally, as a therapist. Some of my teammates and clients relentlessly pursued their ambitions until they achieved what...


Social media-based HIV testing finds new cases
26 May 2016 at 2:30pm
By Andrew M. Seaman (Reuters Health) - Outreach on social media may help encourage men at high risk for HIV infection to get themselves tested, a new study from the U.K. suggests. When researchers advertised home sampling kits to gay and bisexual men through social media and apps, nearly 6,000 men returned saliva or blood sampling kits they requested from the online service. Eighty-two of them were newly diagnosed with the human immunodeficiency virus (HIV) that causes AIDS.


U.S. FDA approves first-ever implant to treat opioid addiction
26 May 2016 at 2:06pm

The first-ever implant to fight addiction to opioids, a class of drugs that includes prescription painkillers and heroin, was approved by the U.S. Food and Drug Administration on Thursday. The matchstick-sized implant, developed by Titan Pharmaceuticals Inc and privately owned Braeburn Pharmaceuticals, is by design less susceptible to abuse or the illicit resale that plagues existing oral therapies. Fewer than half of the estimated 2.2 million Americans who need treatment for opioid abuse are receiving help, according to the U.S. Centers for Human and Health Services (HHS).


Timeline: Zika's origin and global spread
26 May 2016 at 2:05pm
(Reuters) - The following timeline charts the origin and spread of the Zika virus from its discovery nearly 70 years ago: 1947: Scientists researching yellow fever in Uganda's Zika Forest identify the virus in a rhesus monkey 1948: Virus recovered from Aedes africanus mosquito in Zika Forest 1952: First human cases detected in Uganda and Tanzania 1954: Virus found in Nigeria 1960s-80s: Zika detected in mosquitoes and monkeys across equatorial Africa 1969?83: Zika found in equatorial Asia, including India, Indonesia, Malaysia and Pakistan 2007: Zika spreads from Africa and Asia, first large ...


Programs to reduce drinking may not work on fraternity members
26 May 2016 at 1:55pm

By Madeline Kennedy (Reuters Health) - College students who are in so-called Greek letter organizations seem to be immune to programs that work for other students to reduce the use and abuse of alcohol, according to a new review of research on the topic. Fraternity members continue to drink as much and as often as usual, even while enrolled in programs aimed at reducing drinking, and they have the same number of alcohol-related problems ? such as injury, sexual assault and expulsion - as brethren not involved in programs, the researchers conclude in the journal Health Psychology. ?This was somewhat surprising given the success of alcohol risk reduction interventions in other student groups,? said lead author Lori Scott-Sheldon, a senior scientist in the Centers for Behavioral and Preventive Medicine at The Miriam Hospital in Providence, Rhode Island.


New York City can enforce rule on salt warnings in restaurants: court
26 May 2016 at 1:52pm
By Karen Freifeld NEW YORK (Reuters) - New York City can enforce a rule requiring chain restaurants to post warnings on menu items high in sodium, a New York appeals court ruled on Thursday. In February, a New York state judge upheld the rule, knocking down a challenge by the National Restaurant Association. The rule, believed to be the first of its kind in the United States, requires city restaurants with 15 or more locations nationwide to post a salt shaker encased in a black triangle as a warning next to menu items with more than 2,300 milligrams of sodium, the daily limit recommended by the federal government.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC